Literature DB >> 7475882

Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.

H Shinoda1, C C Huang.   

Abstract

The c-jun protein functions as a transcription factor for many genes, and the p53 protein functions as a negative regulator of cellular proliferation, which is related to the apoptosis pathway that induces DNA damage. It has recently been shown that c-jun promotes keratinocyte proliferation and p53 induces apoptosis of various cells. In this study, the presence of c-jun and p53 in cholesteatoma was demonstrated by immunoblotting assays using polyclonal rabbit anti-c-jun antibody and monoclonal anti-p53 protein antibody, respectively. The cholesteatoma tissue incubated with anti-c-jun antibody showed the staining of keratinocytes on the basal and spinous layers of epithelium. The c-jun protein was localized in the basal layer of normal skin, and the p53 protein was present in the nucleus of keratinocytes in the granular layer of cholesteatoma epithelium. The keratinocytes of normal external ear canal skins and normal human skins were slightly stained in the granular layer of the epidermis. The present findings suggest that c-jun and p53 proteins have a role in keratinocyte differentiation, proliferation, and apoptosis in the cholesteatoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7475882     DOI: 10.1288/00005537-199511000-00018

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  11 in total

1.  Apoptosis in the pathogenesis of cholesteatoma in adults.

Authors:  Ewa Olszewska; Stanislaw Chodynicki; Lech Chyczewski
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-12-24       Impact factor: 2.503

2.  Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein.

Authors:  C C Huang; C T Chen; T S Huang; H Shinoda
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

3.  Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.

Authors:  Dong Wook Lee; Jae Ho Chung; Seung Hwan Lee; Chul Won Park; Sung-Ho Kang; Young Ha Oh; Ju Yeon Pyo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-12       Impact factor: 2.503

4.  Induction of cytokine production in cholesteatoma keratinocytes by extracellular high-mobility group box chromosomal protein 1 combined with DNA released by apoptotic cholesteatoma keratinocytes.

Authors:  Zhangcai Chi; Zhengmin Wang; Qiong Liang; Yaying Zhu; Qiang du
Journal:  Mol Cell Biochem       Date:  2014-11-23       Impact factor: 3.396

Review 5.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

6.  Expression of EGFR and Microvessel Density in Middle Ear Cholesteatoma.

Authors:  Bong Joon Jin; Hyun Jung Min; Jin Hyeok Jeong; Chul Won Park; Seung Hwan Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-05-31       Impact factor: 3.372

Review 7.  Updates and knowledge gaps in cholesteatoma research.

Authors:  Chin-Lung Kuo; An-Suey Shiao; Matthew Yung; Masafumi Sakagami; Holger Sudhoff; Chih-Hung Wang; Chyong-Hsin Hsu; Chiang-Feng Lien
Journal:  Biomed Res Int       Date:  2015-03-18       Impact factor: 3.411

Review 8.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

9.  Ossicular chain lesions in cholesteatoma.

Authors:  R Albera; A Canale; E Piumetto; M Lacilla; F Dagna
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-10       Impact factor: 2.124

10.  Large-scale proteomics differentiates cholesteatoma from surrounding tissues and identifies novel proteins related to the pathogenesis.

Authors:  Anders Britze; Rune Isak Dupont Birkler; Niels Gregersen; Therese Ovesen; Johan Palmfeldt
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.